Decreased nNOS in the PVN leads to increased sympathoexcitation in chronic heart failure: Role for CAPON and Ang II

Neeru M. Sharma, Hong Zheng, Parmender P Mehta, Yi Fan Li, Kaushik P Patel

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

AimsPreviously, we showed an enhanced excitatory (N-methyl d-aspartate receptor-NR1) and decreased inhibitory neuronal nitric oxide (NO) synthase (nNOS) influence within the paraventricular nucleus (PVN) of rats with chronic heart failure (CHF). Although NR1 and nNOS are normally linked, they can be disconnected by nNOS sequestering with nNOS-associated protein (CAPON). The aim of this study was to elucidate the underlying mechanism for the disconnection between increased expression of NR1 and decreased nNOS in the PVN of rats with CHF which leads to enhanced sympathoexcitation.Methods and resultsCAPON expression was augmented while nNOS expression was decreased in the PVN of rats with CHF (68 weeks after left coronary artery ligation). Angiotensin II (Ang II) type I receptor (AT1) antagonist losartan (Los) treatment in rats with CHF reduced renal sympathetic nerve activity with concomitant normalization of protein expression of CAPON and nNOS in the PVN. Los treatment also reversed the blunting of endogenous NO-mediated sympatho-inhibition in rats with CHF. Moreover, Ang II-induced increase in CAPON expression in NG108 neuronal cells was also ameliorated by Los.ConclusionBlocking AT1 receptors prevents the overexpression of CAPON and concomitant decrease in nNOS in the PVN, resulting in attenuation of sympathoexcitation commonly observed in CHF. Taken together, our data highlight the importance of altered expression and subsequent interaction of nNOS and CAPON within the PVN, leading to increased sympathoexcitation in CHF. Identifying this crucial nNOS/CAPON interaction regulated by AT1 receptors may provide an important potential therapeutic target in CHF.

Original languageEnglish (US)
Pages (from-to)348-357
Number of pages10
JournalCardiovascular research
Volume92
Issue number2
DOIs
StatePublished - Nov 1 2011

Fingerprint

Paraventricular Hypothalamic Nucleus
Angiotensin II
Heart Failure
Losartan
Angiotensin I
Nitric Oxide Synthase Type I
Angiotensin Receptors
Ligation
Coronary Vessels
Nitric Oxide
Proteins
Kidney

Keywords

  • CAPON
  • Chronic heart failure
  • Paraventricular nucleus
  • Sympathetic nerve activity
  • nNOS

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Decreased nNOS in the PVN leads to increased sympathoexcitation in chronic heart failure : Role for CAPON and Ang II. / Sharma, Neeru M.; Zheng, Hong; Mehta, Parmender P; Li, Yi Fan; Patel, Kaushik P.

In: Cardiovascular research, Vol. 92, No. 2, 01.11.2011, p. 348-357.

Research output: Contribution to journalArticle

Sharma, Neeru M. ; Zheng, Hong ; Mehta, Parmender P ; Li, Yi Fan ; Patel, Kaushik P. / Decreased nNOS in the PVN leads to increased sympathoexcitation in chronic heart failure : Role for CAPON and Ang II. In: Cardiovascular research. 2011 ; Vol. 92, No. 2. pp. 348-357.
@article{bab22662c1d84174a50afabdff066754,
title = "Decreased nNOS in the PVN leads to increased sympathoexcitation in chronic heart failure: Role for CAPON and Ang II",
abstract = "AimsPreviously, we showed an enhanced excitatory (N-methyl d-aspartate receptor-NR1) and decreased inhibitory neuronal nitric oxide (NO) synthase (nNOS) influence within the paraventricular nucleus (PVN) of rats with chronic heart failure (CHF). Although NR1 and nNOS are normally linked, they can be disconnected by nNOS sequestering with nNOS-associated protein (CAPON). The aim of this study was to elucidate the underlying mechanism for the disconnection between increased expression of NR1 and decreased nNOS in the PVN of rats with CHF which leads to enhanced sympathoexcitation.Methods and resultsCAPON expression was augmented while nNOS expression was decreased in the PVN of rats with CHF (68 weeks after left coronary artery ligation). Angiotensin II (Ang II) type I receptor (AT1) antagonist losartan (Los) treatment in rats with CHF reduced renal sympathetic nerve activity with concomitant normalization of protein expression of CAPON and nNOS in the PVN. Los treatment also reversed the blunting of endogenous NO-mediated sympatho-inhibition in rats with CHF. Moreover, Ang II-induced increase in CAPON expression in NG108 neuronal cells was also ameliorated by Los.ConclusionBlocking AT1 receptors prevents the overexpression of CAPON and concomitant decrease in nNOS in the PVN, resulting in attenuation of sympathoexcitation commonly observed in CHF. Taken together, our data highlight the importance of altered expression and subsequent interaction of nNOS and CAPON within the PVN, leading to increased sympathoexcitation in CHF. Identifying this crucial nNOS/CAPON interaction regulated by AT1 receptors may provide an important potential therapeutic target in CHF.",
keywords = "CAPON, Chronic heart failure, Paraventricular nucleus, Sympathetic nerve activity, nNOS",
author = "Sharma, {Neeru M.} and Hong Zheng and Mehta, {Parmender P} and Li, {Yi Fan} and Patel, {Kaushik P}",
year = "2011",
month = "11",
day = "1",
doi = "10.1093/cvr/cvr217",
language = "English (US)",
volume = "92",
pages = "348--357",
journal = "Cardiovascular Research",
issn = "0008-6363",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Decreased nNOS in the PVN leads to increased sympathoexcitation in chronic heart failure

T2 - Role for CAPON and Ang II

AU - Sharma, Neeru M.

AU - Zheng, Hong

AU - Mehta, Parmender P

AU - Li, Yi Fan

AU - Patel, Kaushik P

PY - 2011/11/1

Y1 - 2011/11/1

N2 - AimsPreviously, we showed an enhanced excitatory (N-methyl d-aspartate receptor-NR1) and decreased inhibitory neuronal nitric oxide (NO) synthase (nNOS) influence within the paraventricular nucleus (PVN) of rats with chronic heart failure (CHF). Although NR1 and nNOS are normally linked, they can be disconnected by nNOS sequestering with nNOS-associated protein (CAPON). The aim of this study was to elucidate the underlying mechanism for the disconnection between increased expression of NR1 and decreased nNOS in the PVN of rats with CHF which leads to enhanced sympathoexcitation.Methods and resultsCAPON expression was augmented while nNOS expression was decreased in the PVN of rats with CHF (68 weeks after left coronary artery ligation). Angiotensin II (Ang II) type I receptor (AT1) antagonist losartan (Los) treatment in rats with CHF reduced renal sympathetic nerve activity with concomitant normalization of protein expression of CAPON and nNOS in the PVN. Los treatment also reversed the blunting of endogenous NO-mediated sympatho-inhibition in rats with CHF. Moreover, Ang II-induced increase in CAPON expression in NG108 neuronal cells was also ameliorated by Los.ConclusionBlocking AT1 receptors prevents the overexpression of CAPON and concomitant decrease in nNOS in the PVN, resulting in attenuation of sympathoexcitation commonly observed in CHF. Taken together, our data highlight the importance of altered expression and subsequent interaction of nNOS and CAPON within the PVN, leading to increased sympathoexcitation in CHF. Identifying this crucial nNOS/CAPON interaction regulated by AT1 receptors may provide an important potential therapeutic target in CHF.

AB - AimsPreviously, we showed an enhanced excitatory (N-methyl d-aspartate receptor-NR1) and decreased inhibitory neuronal nitric oxide (NO) synthase (nNOS) influence within the paraventricular nucleus (PVN) of rats with chronic heart failure (CHF). Although NR1 and nNOS are normally linked, they can be disconnected by nNOS sequestering with nNOS-associated protein (CAPON). The aim of this study was to elucidate the underlying mechanism for the disconnection between increased expression of NR1 and decreased nNOS in the PVN of rats with CHF which leads to enhanced sympathoexcitation.Methods and resultsCAPON expression was augmented while nNOS expression was decreased in the PVN of rats with CHF (68 weeks after left coronary artery ligation). Angiotensin II (Ang II) type I receptor (AT1) antagonist losartan (Los) treatment in rats with CHF reduced renal sympathetic nerve activity with concomitant normalization of protein expression of CAPON and nNOS in the PVN. Los treatment also reversed the blunting of endogenous NO-mediated sympatho-inhibition in rats with CHF. Moreover, Ang II-induced increase in CAPON expression in NG108 neuronal cells was also ameliorated by Los.ConclusionBlocking AT1 receptors prevents the overexpression of CAPON and concomitant decrease in nNOS in the PVN, resulting in attenuation of sympathoexcitation commonly observed in CHF. Taken together, our data highlight the importance of altered expression and subsequent interaction of nNOS and CAPON within the PVN, leading to increased sympathoexcitation in CHF. Identifying this crucial nNOS/CAPON interaction regulated by AT1 receptors may provide an important potential therapeutic target in CHF.

KW - CAPON

KW - Chronic heart failure

KW - Paraventricular nucleus

KW - Sympathetic nerve activity

KW - nNOS

UR - http://www.scopus.com/inward/record.url?scp=80054091696&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054091696&partnerID=8YFLogxK

U2 - 10.1093/cvr/cvr217

DO - 10.1093/cvr/cvr217

M3 - Article

C2 - 21831995

AN - SCOPUS:80054091696

VL - 92

SP - 348

EP - 357

JO - Cardiovascular Research

JF - Cardiovascular Research

SN - 0008-6363

IS - 2

ER -